血塞通联合拜阿斯匹林治疗急性脑梗死的临床随机平行对照研究  

Effect of Xuesaitong Combined with Aspirin in the Treatment of Acute Cerebral Infarction: A Randomized Controlled Study

作　　者：杨军华 YANG Jun-hua(Department of Neurology,Kaifeng Central Hospital,Kaifeng,Henan,475000,China)

机构地区：[1]开封市中心医院神经内科,河南开封475000

出　　处：《临床研究》2017年第12期80-81,共2页Clinical Research

摘　　要：目的研究血塞通联合拜阿斯匹林治疗急性脑梗死的临床疗效。方法以2015年3月~2016年2月本院收治的120例急性脑梗死患者为研究对象,按随数字法分为对照组和观察组,对照组接受丹参注射液,观察组接受血塞通联合拜阿司匹林治疗,以神经功能损伤、生活能力评分等为评价指标,评价血塞通联合拜阿斯匹林治疗急性脑梗死临床疗效。结果观察组神经功能损伤及生活能力评分与对照组相比均较低,差异显著(P<005);观察组总有效百分比933%,高于对照组的780%(P<005)。结论血塞通联合拜阿斯匹林治疗急性脑梗死临床效果显著,提高患者生活质量,值得临床推广。Objective To investigate the clinical efficacy of Xuesaitong combined with aspirin in the treatment of acute cerebral infarction Methods A total of120patients with acute cerebral infarction from March2015to Feburary2016were divided into the control group and observation group using random number table The control group was treated with Salvia miltiorrhiza injection The observation group received Xuesaitong combined with aspirin The neurological impairment,and life ability score were used as indexes to evaluate the clinical efficacy of Xuesaitong combined with aspirin in the treatment of acute cerebral infarction Results The scores of neurological impairment and life ability of the observation group were lower than those of the control group(P<005)The total effective percentage of the observation group was higher than that of the control group(933%vs780%,P<005)Conclusion Xuesaitong combined with aspirin has a great effect on the patients with acute cerebral infarction,which improve the quality of life The combined treatment is worthy of clinical application

关 键 词：血塞通 拜阿斯匹林 急性脑梗死 临床疗效 

分 类 号：R277.7[医药卫生—中医学]